Skip to main content

Advertisement

SpringerLink
Log in

The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

The incidence of nonsustained ventricular tachycardia (NSVT) after myocardial infarction (MI), has decreased significantly in the thrombolytic era and may not have a high enough power to predict sudden cardiac death or all-cause mortality post-MI. Nonetheless, noninvasive algorithms that utilize the combination of NSVT with left ventricular dysfunction, abnormal signal-averaged electrocardiogram, and heart rate variability can be used for better risk assessment. Recent multicenter studies have provided strong evidence for the use of an implantable cardioverter defibrillator in patients with NSVT and inducible sustained ventricual tachycardia. On the other hand anti-arrhythmic drugs have no role and most are harmful in asypmtomatic patients post-MI with NSVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bigger JT, Fleiss JL, Rolnitzky LM, and the Multicenter Post — Infarction Research Group: Prevalence, characteristics, and significance of ventricular tachycardia detected by 24-hour continuous recordings in the late hospital phase of myocardial infarction. Am J Cardiol 1986, 58:1151–1160.

    Article  PubMed  Google Scholar 

  2. Andresen D, Bethge KP, Boissel JP, et al., for the European Infarction Study Group: Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. Eur Heart J 1990, 11:529–536.

    PubMed  CAS  Google Scholar 

  3. Maggionni AP, Zuanetti G, Franzosi MG, et al., on behalf of the GISSI Investigators: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI — II results. Circulation 1993, 87:312 322.

    Google Scholar 

  4. Hohnloser SH, Klingenheben T, Zabel M et al.: Prevalence, Characteristics and Prognostic Value during Long Term Follow - Up of Non-Sustained Tachycardia after Myocardial Infarction in the Thrombolytic Era. J Am Coll Cardiol 1999, 33: 1895–1902. This article confirms the findings of Maggionni et al. [3] demonstrating a decline in the incidence of NSVT and its prognostic impact post-MI in the thrombolytic era.

    Article  PubMed  CAS  Google Scholar 

  5. Kostis JB, Byington R, Friedman LM et al., for the BHAT Study Group: Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol 1987, 10:231–242.

    Article  PubMed  CAS  Google Scholar 

  6. Bigger JT, Fleiss JL, Kleiger R et al., and the Multicenter Post - Infarction Research Group: The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality 2 years after myocardial infarction. Circulation 1984, 69:250–258.

    PubMed  Google Scholar 

  7. Touboul P, Andre-Fouet X, Leizorovicz A et al., for The Groupe detude du prognostic de linfarctus du myocardie (GREPI): Eur Heart J 1997, 18 99–107.

    PubMed  CAS  Google Scholar 

  8. Gomes JA, Winters SL, Stewart D, et al.: A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J am Coll Cardiol 1987, 10:349–357.

    Article  PubMed  CAS  Google Scholar 

  9. Kuchar DL, Thorburn CQ, Sammel NL: Late potentials detected after myocardial infarction: Natural history and prognostic significance. Circulation 1986, 74:1280–1289.

    PubMed  CAS  Google Scholar 

  10. El-Sherif N, Ursell S, Bekheit S, et al.: Prognostic significance of the signal-averaged electrocardiogram depends on the time of recording in the post-infarction period. Am Heart J 1989, 118 256–264.

    Article  PubMed  CAS  Google Scholar 

  11. Farrell TG, Bashir Y, Cripps T, et al.: Risk stratification for arrhythmic events in post-myocardial infarction patients based on heart rate variability, ambulatory electro-cardiographic variables and the signal-averaged ECG. J Am Coll Cardiol 1991, 18:687 697.

    Article  PubMed  Google Scholar 

  12. Pedretti R, Etro MD, Laporta A, et al.: Prediction of late arrhythmic events after acute myocardial infarction from combined use of non-invasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993, 71:1131–1141.

    Article  PubMed  CAS  Google Scholar 

  13. El-Sherif N, Denes P, Katz R, et al., and the CASTSA-ECG Sub-study Investigators: Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995, 25 908 914.

    PubMed  Google Scholar 

  14. Reinhardt L, Makijarv M, Fetsch T, et al.: Noninvasive risk modeling after myocardial infarction Am J Cardiol 1996, 78:627–632.

    Article  PubMed  CAS  Google Scholar 

  15. Echt DS, Liebson PR, Mitchell LB, et al.: Mortality and morbidity in patients receiving encainide, flecainide or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781–788.

    Article  PubMed  CAS  Google Scholar 

  16. Gomes JAC, Hariman RI, Kang PS et al.: Programmed electrical stimulation in patients with high grade ectopy. Electrophysiologic findings and prognosis for survival. Circulation 1984, 70:43–51.

    PubMed  CAS  Google Scholar 

  17. Buxton AF, Marchlinski FE, Flores BF, et al.: Nonsustained ventricular tachycardia in patients with coronary artery disease; Role of electrophysiologic study. Circulation 1987, 75:1178–1185.

    PubMed  CAS  Google Scholar 

  18. Kuchar DL, Thorburn CW, Samuel NL: Prediction of Serious Arrhythmic Events after Myocardial Infarction. Signal-Averaged Electrocardiogram, Holter Monitoring and Radionuclide and ventriculography J Am Coll Cardiol 1987, 9:531–538.

    Article  PubMed  CAS  Google Scholar 

  19. Kleiger RE, Miller P, Bigger JT, Moss AJ: Decreased heart rate variability and its association with increased mortality after myocardial infarction. Am J Cardiol 1987, 59 256–262.

    Article  PubMed  CAS  Google Scholar 

  20. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary Report: Effects of encainide and flecainide on mortality in a randomized trial of arrhythmic suppression after myocardial infarction. N Engl J Med 1989, 321:406–412.

    Article  Google Scholar 

  21. The Cardiac Arrhythmic Suppression Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1991, 327:227–233.

    Google Scholar 

  22. Impact Research Group: International mexilitine and placebo antiarrhythmic coronary trial: Report on arrhythmia and other findings. J Am Coll Cardiol 1984, 4:148–163.

    Google Scholar 

  23. UK Rhythmodan Multicenter Study Group: Oral disopyramide after admission to hospital with suspected acute myocardial infarction. Postgrad Med J 1984, 60:98–107.

    Google Scholar 

  24. Waldo Al, Camm AJ, deRuyter H, et al., for the SWORD investigators: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996, 348:7–12.

    Article  PubMed  CAS  Google Scholar 

  25. Hine LK, Laird NM, Hewitt P, Chalmers TC: Meta-Analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. J Am Med Assoc 1989, 262:3037–3040.

    Article  CAS  Google Scholar 

  26. Hjalmarson A, Elmfeldt D, Herlitz J, et al.: Effect on mortality of metoprolol in acute myocardial infarction. A double blind randomized trial. Lancet 1981, ii:823–827.

    Article  Google Scholar 

  27. ISIS-1 (First International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986, ii:57–66.

    Google Scholar 

  28. Multicenter International Study: Improvement of prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. Br Med J 1975, 3:735–740.

    Article  Google Scholar 

  29. Multicenter International Study: Reduction in mortality after myocardial infarction with long-term beta-adrenoreceptor blockage: Supplementary report. Br Med J 1977, 2:419 425.

    Google Scholar 

  30. The Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981, 304:801–807.

    Article  Google Scholar 

  31. Beta-Blocker Heart Attack Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. Mortality results. J Am Med Assoc 1982, 247:1707–1714.

    Article  Google Scholar 

  32. Cairns JA, Connolly SJ, Roberts R, Gent M: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisatios: CAMIAT. Canadian Amiodarone Myocardial Infarction Arryth mia Trial Investigators. Lancet 1997, 349(9053):675–682.

    Article  PubMed  CAS  Google Scholar 

  33. Julian DG, Camm AJ, Frangin G, et al.: Randomized trial of effect amiodarone on mortality in patients with leftventricular dysfunction after recent myocardial inarction EMIAT. European Myocardial Infarct Amiodarone Trial Investigators; Lancet 1997, 349(9053):667–674.

    Article  PubMed  CAS  Google Scholar 

  34. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Eng J Med 1996, 335(26):1933–1940.

    Article  CAS  Google Scholar 

  35. Buxton A: Late breaking clinical trial I: Cardia Therapeutic, 1999. Located on Internet site http://www.medscape.com/Medscape/CNO/1999/ACC/eng/03.08/0405.daut/0405.daut.htmp. The findings of this study are not yet published. However the study shows that EP-guided therapy is superior to no therapy in pts with inducible VT who have asymptomatic NSVT with LV dysfuntion. However the benefit was conferred in patients who had an ICD EP-guided drug therapy was not beneficial.

  36. Gomes JA, Mehta D, John IP, et al.: Predictors of long-term survival in patients with malignant ventricular arrhythmias. Am J Cardiol 1997, 79: 1054–1060

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Electrophysiology and Electrocardiography Section, Cardiovascular Institute, Mt. Sinai Medical Center, 1 Gustave L. Levy Place, Box 1054, 10029, New York, NY, USA

    J. Anthony Gomes MD, FACC (Director)

Authors
  1. J. Anthony Gomes MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gomes, J.A. The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia. Curr Cardiol Rep 1, 297–301 (1999). https://doi.org/10.1007/s11886-999-0053-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-999-0053-5

Keywords

Search

Navigation